These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 9537438)

  • 61. Expression profiling and differential screening between hepatoblastomas and the corresponding normal livers: identification of high expression of the PLK1 oncogene as a poor-prognostic indicator of hepatoblastomas.
    Yamada S; Ohira M; Horie H; Ando K; Takayasu H; Suzuki Y; Sugano S; Hirata T; Goto T; Matsunaga T; Hiyama E; Hayashi Y; Ando H; Suita S; Kaneko M; Sasaki F; Hashizume K; Ohnuma N; Nakagawara A
    Oncogene; 2004 Aug; 23(35):5901-11. PubMed ID: 15221005
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Virtually 100% of melanoma cell lines harbor alterations at the DNA level within CDKN2A, CDKN2B, or one of their downstream targets.
    Walker GJ; Flores JF; Glendening JM; Lin AH; Markl ID; Fountain JW
    Genes Chromosomes Cancer; 1998 Jun; 22(2):157-63. PubMed ID: 9598804
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Screening of germline mutations in the CDKN2A and CDKN2B genes in Swedish families with hereditary cutaneous melanoma.
    Platz A; Hansson J; Månsson-Brahme E; Lagerlof B; Linder S; Lundqvist E; Sevigny P; Inganäs M; Ringborg U
    J Natl Cancer Inst; 1997 May; 89(10):697-702. PubMed ID: 9168184
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Germline and somatic mutations in cyclin-dependent kinase inhibitor genes CDKN1A, CDKN2B, and CDKN2C in sporadic parathyroid adenomas.
    Costa-Guda J; Soong CP; Parekh VI; Agarwal SK; Arnold A
    Horm Cancer; 2013 Oct; 4(5):301-7. PubMed ID: 23715670
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Screening of germline mutations in the CDK4, CDKN2C and TP53 genes in familial melanoma: a clinic-based population study.
    Platz A; Hansson J; Ringborg U
    Int J Cancer; 1998 Sep; 78(1):13-5. PubMed ID: 9724087
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Fetal- and tumor-specific regulation of growth hormone receptor messenger RNA expression in human liver.
    Zogopoulos G; Albrecht S; Pietsch T; Alpert L; von Schweinitz D; Lefèbvre Y; Goodyer CG
    Cancer Res; 1996 Jul; 56(13):2949-53. PubMed ID: 8674047
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Promoter hypermethylation inactivates CDKN2A, CDKN2B and RASSF1A genes in sporadic parathyroid adenomas.
    Arya AK; Bhadada SK; Singh P; Sachdeva N; Saikia UN; Dahiya D; Behera A; Bhansali A; Rao SD
    Sci Rep; 2017 Jun; 7(1):3123. PubMed ID: 28600574
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Amplification of cyclin genes in colorectal carcinomas.
    Leach FS; Elledge SJ; Sherr CJ; Willson JK; Markowitz S; Kinzler KW; Vogelstein B
    Cancer Res; 1993 May; 53(9):1986-9. PubMed ID: 8481900
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Identification of two distinct deleted regions on the short arm of chromosome 1 and rare mutation of the CDKN2C gene from 1p32 in oligodendroglial tumors.
    Husemann K; Wolter M; Büschges R; Boström J; Sabel M; Reifenberger G
    J Neuropathol Exp Neurol; 1999 Oct; 58(10):1041-50. PubMed ID: 10515227
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Characterization of the continuous cell line HepT1 derived from a human hepatoblastoma.
    Pietsch T; Fonatsch C; Albrecht S; Maschek H; Wolf HK; von Schweinitz D
    Lab Invest; 1996 Apr; 74(4):809-18. PubMed ID: 8606490
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Expression and regulation of G1 cell-cycle inhibitors (p16INK4A, p15INK4B, p18INK4C, p19INK4D) in human acute myeloid leukemia and normal myeloid cells.
    Schwaller J; Pabst T; Koeffler HP; Niklaus G; Loetscher P; Fey MF; Tobler A
    Leukemia; 1997 Jan; 11(1):54-63. PubMed ID: 9001419
    [TBL] [Abstract][Full Text] [Related]  

  • 72. An AC-repeat adjacent to mouse Cdkn2B allows the detection of specific allelic losses in the p15INK4b and p16INK4a tumor suppressor genes.
    Malumbres M; Pérez de Castro I; Santos J; Pérez-Ollé R; Fernández-Piqueras J; Pellicer A
    Mamm Genome; 1998 Mar; 9(3):183-5. PubMed ID: 9501299
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Expression of the leukemia-associated gene, p18, in normal and malignant tissues; inactivation of expression in a patient with cleaved B cell lymphoma/leukemia.
    Ghosh PK; Anderson J; Cohen N; Takeshita K; Atweh GF; Lebowitz P
    Oncogene; 1993 Oct; 8(10):2869-72. PubMed ID: 8397372
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Loss of maternal alleles on chromosome arm 11p in hepatoblastoma.
    Albrecht S; von Schweinitz D; Waha A; Kraus JA; von Deimling A; Pietsch T
    Cancer Res; 1994 Oct; 54(19):5041-4. PubMed ID: 7923113
    [TBL] [Abstract][Full Text] [Related]  

  • 75. CDKN2A, CDKN2B and p14ARF are frequently and differentially methylated in ependymal tumours.
    Rousseau E; Ruchoux MM; Scaravilli F; Chapon F; Vinchon M; De Smet C; Godfraind C; Vikkula M
    Neuropathol Appl Neurobiol; 2003 Dec; 29(6):574-83. PubMed ID: 14636164
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Arsenic trioxide inhibits DNA methyltransferase and restores expression of methylation-silenced CDKN2B/CDKN2A genes in human hematologic malignant cells.
    Fu HY; Shen JZ; Wu Y; Shen SF; Zhou HR; Fan LP
    Oncol Rep; 2010 Aug; 24(2):335-43. PubMed ID: 20596618
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Interferon-γ activates expression of p15 and p16 regardless of 9p21.3 coronary artery disease risk genotype.
    Almontashiri NA; Fan M; Cheng BL; Chen HH; Roberts R; Stewart AF
    J Am Coll Cardiol; 2013 Jan; 61(2):143-7. PubMed ID: 23199516
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Decreased expression of the INK4 family of cyclin-dependent kinase inhibitors in Wilms tumor.
    Arcellana-Panlilio MY; Egeler RM; Ujack E; Pinto A; Demetrick DJ; Robbins SM; Coppes MJ
    Genes Chromosomes Cancer; 2000 Sep; 29(1):63-9. PubMed ID: 10918395
    [TBL] [Abstract][Full Text] [Related]  

  • 79. ANRIL expression is associated with atherosclerosis risk at chromosome 9p21.
    Holdt LM; Beutner F; Scholz M; Gielen S; Gäbel G; Bergert H; Schuler G; Thiery J; Teupser D
    Arterioscler Thromb Vasc Biol; 2010 Mar; 30(3):620-7. PubMed ID: 20056914
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Expression profiles and clinical relationships of ID2, CDKN1B, and CDKN2A in primary neuroblastoma.
    Gebauer S; Yu AL; Omura-Minamisawa M; Batova A; Diccianni MB
    Genes Chromosomes Cancer; 2004 Dec; 41(4):297-308. PubMed ID: 15390183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.